Gosebruch Henry O
Insider CIK 1659625 · ANIP Director · ABBV EVP, Chief Strategy Officer · APTX Director · NMRA President & CEO, Director · SLRN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANIP ANI PHARMACEUTICALS INC | A Award | 2026-08-19 | 2026-08-27 | 6,662 | — | $0 | 6,662 | SEC↗ |
| ANIP ANI PHARMACEUTICALS INC | A Award | 2026-08-19 | 2026-08-27 | 6,662 | — | $0 | 6,662 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 155,450 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 92,158 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer | 2025-05-21 | 2025-05-23 | 50,000 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award deriv | 2024-06-07 | 2024-06-11 | 92,158 | — | $0 | 92,158 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 160,000 | — | $0 | 160,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award | 2024-02-14 | 2024-02-16 | 80,000 | — | $0 | 462,345 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-19 | 2023-09-19 | 15,000 | $12.62 | $189.3K | 15,000 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 155,450 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 155,450 | — | $0 | 155,450 | SEC↗ |
| SLRN ACELYRIN, Inc. | P Buy | 2023-05-09 | 2023-05-11 | 50,000 | $18.00 | $900.0K | 50,000 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2022-05-26 | 2022-05-31 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2022-05-16 | 2022-05-18 | 83,960 | $54.86 | $4.61M | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2022-05-16 | 2022-05-20 | 83,960 | $54.86 | $4.61M | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-05-16 | 2022-05-18 | 83,960 | $155.00 | $13.01M | 16,623 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2022-05-16 | 2022-05-18 | 83,960 | $54.86 | $4.61M | 100,583 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2022-05-16 | 2022-05-20 | 83,960 | $54.86 | $4.61M | 125,583 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-05-16 | 2022-05-20 | 83,960 | $155.00 | $13.01M | 41,623 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-03-01 | 2022-05-20 | 4,000 | $148.71 | $594.8K | 53,600 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-03-01 | 2022-05-20 | 100 | $149.38 | $14.9K | 53,500 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-03-01 | 2022-05-20 | 5,167 | $147.60 | $762.6K | 57,600 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-03-01 | 2022-05-20 | 15,733 | $146.81 | $2.31M | 62,767 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-03-01 | 2022-03-01 | 1,101 | $149.14 | $164.2K | 41,623 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-03-01 | 2022-03-01 | 8,303 | $148.62 | $1.23M | 42,724 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-03-01 | 2022-03-01 | 5,596 | $147.54 | $825.6K | 51,027 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-03-01 | 2022-03-02 | 100 | $149.38 | $14.9K | 16,623 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-03-01 | 2022-03-02 | 4,000 | $148.71 | $594.8K | 16,723 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-03-01 | 2022-03-02 | 5,167 | $147.60 | $762.6K | 20,723 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2022-03-01 | 2022-03-02 | 15,733 | $146.81 | $2.31M | 25,890 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2022-02-25 | 2022-03-01 | 30,156 | $149.54 | $4.51M | 56,623 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2022-02-17 | 2022-02-22 | 30,647 | — | $0 | 30,647 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2022-02-17 | 2022-02-22 | 8,701 | — | $0 | 86,779 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2022-02-17 | 2022-02-22 | 36,673 | — | $0 | 55,384 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2022-02-17 | 2022-02-22 | 14,722 | — | $0 | 78,078 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2022-02-17 | 2022-02-22 | 7,972 | — | $0 | 63,356 | SEC↗ |
| ABBV AbbVie Inc. | G Gift | 2021-09-07 | 2021-09-10 | 30,000 | — | $0 | 18,711 | SEC↗ |
| ABBV AbbVie Inc. | G Gift | 2021-09-07 | 2021-09-10 | 30,000 | — | $0 | 78,500 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2021-05-27 | 2021-06-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2021-02-28 | 2021-03-02 | 22,833 | $107.74 | $2.46M | 48,711 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2021-02-18 | 2021-02-22 | 49,068 | — | $0 | 49,068 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2021-02-18 | 2021-02-22 | 6,555 | — | $0 | 48,848 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2021-02-18 | 2021-02-22 | 7,972 | — | $0 | 56,820 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2021-02-18 | 2021-02-22 | 14,724 | — | $0 | 71,544 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2021-02-18 | 2021-02-22 | 22,287 | — | $0 | 42,293 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-12-31 | 2021-01-05 | 5,339 | $2.22 | $11.9K | 5,339 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2020-11-20 | 2020-11-24 | 6,900 | $98.83 | $681.9K | 53,106 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2020-11-20 | 2020-11-24 | 33,100 | $99.49 | $3.29M | 20,006 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-09-30 | 2020-10-02 | 5,490 | $2.16 | $11.9K | 5,490 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-06-30 | 2020-07-02 | 4,051 | $2.68 | $10.9K | 4,051 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-05-20 | 2020-05-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ABBV AbbVie Inc. | G Gift | 2020-04-06 | 2020-04-24 | 18,500 | — | $0 | 60,006 | SEC↗ |
| ABBV AbbVie Inc. | G Gift | 2020-04-06 | 2020-04-24 | 18,500 | — | $0 | 48,500 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-03-31 | 2020-04-02 | 7,374 | $1.36 | $10.0K | 7,374 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2020-02-28 | 2020-03-03 | 26,038 | $85.42 | $2.22M | 78,506 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2020-02-20 | 2020-02-24 | 96,563 | — | $0 | 96,563 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2020-02-20 | 2020-02-24 | 7,972 | — | $0 | 104,544 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2020-02-20 | 2020-02-24 | 32,524 | — | $0 | 78,287 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2020-02-20 | 2020-02-24 | 11,730 | — | $0 | 90,017 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2020-02-20 | 2020-02-24 | 6,555 | — | $0 | 96,572 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2020-01-10 | 2020-01-14 | 25,000 | $3.00 | $75.0K | 125,000 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2019-12-31 | 2020-01-03 | 4,668 | $2.14 | $10.0K | 4,668 | SEC↗ |
| APTX Aptinyx Inc. | G Gift | 2019-10-04 | 2019-10-07 | 100,000 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | G Gift | 2019-10-04 | 2019-10-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2019-09-30 | 2019-10-02 | 4,419 | $2.08 | $9.2K | 4,419 | SEC↗ |
| ABBV AbbVie Inc. | G Gift | 2019-08-14 | 2019-08-16 | 30,000 | — | $0 | 45,763 | SEC↗ |
| ABBV AbbVie Inc. | G Gift | 2019-08-14 | 2019-08-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ABBV AbbVie Inc. | P Buy | 2019-07-29 | 2019-07-31 | 30,000 | $67.28 | $2.02M | 75,763 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2019-06-28 | 2019-07-02 | 2,649 | $1.98 | $5.2K | 2,649 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2019-05-15 | 2019-05-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2019-05-08 | 2019-05-09 | 96,580 | $3.86 | $372.8K | 100,000 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2019-05-07 | 2019-05-09 | 3,420 | $3.75 | $12.8K | 3,420 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2019-02-28 | 2019-03-04 | 22,956 | $79.41 | $1.82M | 45,763 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2019-02-21 | 2019-02-22 | 49,065 | — | $0 | 49,065 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 6,555 | — | $0 | 68,719 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 11,730 | — | $0 | 62,164 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 19,495 | — | $0 | 36,399 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 14,035 | — | $0 | 50,434 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2018-12-09 | 2018-12-11 | 13,446 | $86.96 | $1.17M | 16,904 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2018-11-29 | 2018-11-30 | 42,450 | $90.10 | $3.82M | 30,350 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2018-02-28 | 2018-03-02 | 17,418 | $118.26 | $2.06M | 72,800 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2018-02-15 | 2018-02-16 | 35,440 | — | $0 | 35,440 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2018-02-15 | 2018-02-16 | 13,552 | — | $0 | 78,488 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2018-02-15 | 2018-02-16 | 14,034 | — | $0 | 64,936 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2018-02-15 | 2018-02-16 | 11,730 | — | $0 | 90,218 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2017-12-09 | 2017-12-11 | 14,235 | $95.95 | $1.37M | 50,902 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-10-30 | 2017-10-31 | 4,482 | $91.22 | $408.8K | 65,237 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-10-30 | 2017-10-31 | 2,150 | $89.38 | $192.2K | 81,287 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-10-30 | 2017-10-31 | 11,568 | $90.49 | $1.05M | 69,719 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-10-30 | 2017-10-31 | 100 | $92.02 | $9.2K | 65,137 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 100 | $70.01 | $7.0K | 95,974 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 5,663 | $70.00 | $396.4K | 96,074 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 1,537 | $70.01 | $107.6K | 94,437 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 100 | $70.34 | $7.0K | 83,737 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 100 | $70.29 | $7.0K | 83,837 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 200 | $70.25 | $14.1K | 83,937 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 600 | $70.23 | $42.1K | 84,137 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 400 | $70.22 | $28.1K | 84,737 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 700 | $70.21 | $49.1K | 85,137 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 500 | $70.20 | $35.1K | 85,837 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 1,200 | $70.19 | $84.2K | 86,337 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 300 | $70.19 | $21.1K | 87,537 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 500 | $70.18 | $35.1K | 87,837 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 200 | $70.18 | $14.0K | 88,337 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 400 | $70.17 | $28.1K | 88,537 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 600 | $70.16 | $42.1K | 88,937 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 100 | $70.15 | $7.0K | 89,537 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 100 | $70.14 | $7.0K | 89,637 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 800 | $70.13 | $56.1K | 89,737 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 700 | $70.12 | $49.1K | 90,537 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 200 | $70.12 | $14.0K | 91,237 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 1,000 | $70.11 | $70.1K | 91,437 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 400 | $70.10 | $28.0K | 92,437 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 100 | $70.09 | $7.0K | 92,837 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 100 | $70.08 | $7.0K | 92,937 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 400 | $70.07 | $28.0K | 93,037 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 100 | $70.05 | $7.0K | 93,437 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 300 | $70.04 | $21.0K | 93,537 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 600 | $70.02 | $42.0K | 93,837 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 200 | $70.45 | $14.1K | 83,437 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-07-31 | 2017-08-02 | 100 | $70.37 | $7.0K | 83,637 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2017-02-28 | 2017-03-02 | 20,673 | $62.22 | $1.29M | 101,737 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2017-02-16 | 2017-02-21 | 78,340 | — | $0 | 78,340 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2017-02-16 | 2017-02-21 | 31,196 | — | $0 | 108,375 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2017-02-16 | 2017-02-21 | 14,035 | — | $0 | 122,410 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2016-12-09 | 2016-12-09 | 13,871 | $60.90 | $844.7K | 77,179 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2016-02-18 | 2016-02-22 | 83,960 | — | $0 | 83,960 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2015-12-09 | 2015-12-11 | 26,510 | — | $0 | 26,510 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2015-12-09 | 2015-12-11 | 64,540 | — | $0 | 91,050 | SEC↗ |